BioBlocks’ CFL: Designed for Improved Lead Discovery Screenable compounds in BioBlocks’ newly available Comprehensive Fragment Library (CFL) are selected for their improved chemical and pharmaceutical properties. Unlike traditional fragment screening sets of predominantly flat aromatic compounds, the typical CFL fragment features both aromatic and sp3 character in 15 atoms or less, with >95% containing handles […]
Read MorePATIENT RECRUITMENT: A PERSONALIZED APPROACH April 05, 2018 I recently had the opportunity to visit with a few physicians in Central and Eastern Europe (CEE) and learn about their approach with clinical trials and patient recruitment. For our non-EU clients considering a clinical research in the EU, some differences in patient recruitment may be […]
Read MoreData exchange can be one of the biggest challenges impacting relationships between CROs and sponsors. How does your company overcome this issue and what standards of practice can be followed to mitigate issues? Data exchange is a part of the much broader issue of confidentiality when contracting R&D services. In reality, regardless of the geographic […]
Read MoreWebinar- Fast, Quality Clinical Trials for Less; Let Melbourne, Australia be your Partner
Read MoreAustralia tax incentives spurring R&D March 27, 2018 Australia is riding a wave of R&D, thanks to generous government tax incentives, as well as the quality of contract research and speed of performing clinical trials. The incentives provide businesses investing in eligible R&D, including clinical trials, with: A 43.5% refundable R&D tax offset for a […]
Read More
Improved Fragment Screening with BioBlocks’ CFL BioBlocks’ Comprehensive Fragment Library (CFL) provides a powerful advantage for identifying high quality starting points for lead discovery and is now ready for drug discovery collaborations. As part of the Leap-to-Lead™ platform, the CFL was designed to meet strict property criteria, aided by our team’s deep expertise in medicinal […]
Read MoreAccelovance & Linical Merge Organizations to Form a Best-in-Class CRO with Increased Global Reach ROCKVILLE, MD – March 26, 2018 – Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in oncology, vaccines, and general medicine announced today that it has signed a merger agreement with Linical, a leading CRO based in Asia in […]
Read MoreEU GDP Guidelines: Implications for Shipping Clinical Materials into the European Market Recently, the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) opened an investigation into a patient complaint of mold on paracetamol (acetaminophen) tablets.1 It discovered the product was shipped by sea from India to multiple companies in the U.K. at temperatures reaching […]
Read More